Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-10-26
DOI
10.3389/fimmu.2017.01371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis
- (2017) Caroline J. Voskens et al. INFLAMMATORY BOWEL DISEASES
- A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation
- (2016) Satoru Todo et al. HEPATOLOGY
- Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation
- (2016) Niloufar Safinia et al. Oncotarget
- Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
- (2015) C. G. Brunstein et al. BLOOD
- Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo
- (2015) Anika Fischer et al. GUT
- Type 1 diabetes immunotherapy using polyclonal regulatory T cells
- (2015) Jeffrey A. Bluestone et al. Science Translational Medicine
- Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease
- (2015) Mareike Florek et al. PLoS One
- HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
- (2014) M. F. Martelli et al. BLOOD
- Therapy of type 1 diabetes with CD4+CD25highCD127-regulatory T cells prolongs survival of pancreatic islets — Results of one year follow-up
- (2014) Natalia Marek-Trzonkowska et al. CLINICAL IMMUNOLOGY
- CXCR3+CCR5+ T cells and autoimmune diseases: guilty as charged?
- (2014) Charles R. Mackay JOURNAL OF CLINICAL INVESTIGATION
- Regulatory T Cells as Immunotherapy
- (2014) Benjamin D. Singer et al. Frontiers in Immunology
- Challenges in cryopreservation of regulatory T cells (Tregs) for clinical therapeutic applications
- (2013) Karolina Golab et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
- (2012) Pierre Desreumaux et al. GASTROENTEROLOGY
- Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
- (2011) M. Di Ianni et al. BLOOD
- Regulatory T cells and Foxp3
- (2011) Alexander Y. Rudensky IMMUNOLOGICAL REVIEWS
- Regulatory T cells expanded by rapamycin in vitro suppress colitis in an experimental mouse model
- (2011) Haruei Ogino et al. JOURNAL OF GASTROENTEROLOGY
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
- (2010) C. G. Brunstein et al. BLOOD
- Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice
- (2010) Michio Tomura et al. JOURNAL OF CLINICAL INVESTIGATION
- First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
- (2009) Piotr Trzonkowski et al. CLINICAL IMMUNOLOGY
- Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
- (2009) Maria A. Curotto de Lafaille et al. IMMUNITY
- Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function
- (2009) Maciej Kmieciak et al. Journal of Translational Medicine
- Ex vivo expansion of CD4+CD25+T regulatory cells for immunosuppressive therapy
- (2008) Piotr Trzonkowski et al. CYTOMETRY PART A
- Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells
- (2008) M. Nagar et al. INTERNATIONAL IMMUNOLOGY
- Clinical Grade Treg: GMP Isolation, Improvement of Purity by CD127pos Depletion, Treg Expansion, and Treg Cryopreservation
- (2008) Jorieke H. Peters et al. PLoS One
- Natural and TGF-β–induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each other
- (2008) David A. Horwitz et al. TRENDS IN IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started